Ohio
|
|
1-13292
|
|
31-1414921
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
14111
Scottslawn Road, Marysville, Ohio 43041
|
(Address
of principal executive offices) (Zip Code)
|
(937) 644-0011
|
(Registrant’s
telephone number, including area code)
|
Not
applicable
|
(Former
name or former address, if changed since last report)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
|
(a)
|
|
Financial
statements of businesses acquired:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(b)
|
|
Pro
forma financial information:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(c)
|
|
Shell
company transactions:
|
||
|
|||||
|
|
|
Not
applicable.
|
||
|
|||||
|
(d)
|
|
Exhibits:
|
Exhibit No.
|
|
Description
|
|||
|
|
|
|||
99.1
|
|
News
Release issued by The Scotts Miracle-Gro Company on May 5,
2008
|
THE
SCOTTS MIRACLE-GRO COMPANY
|
||
|
|
|
Dated:
May 5, 2008
|
By: |
/s/
David C. Evans
|
Printed
Name: David C. Evans
|
||
Title:
Executive Vice President and Chief Financial
Officer
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
News
Release issued by The Scotts Miracle-Gro Company on May 5,
2008
|
The
Scotts Miracle-Gro Company
|
NEWS
|
·
|
Although
consumer purchases have been strong in recent weeks, the Company
expects
consumer purchases to be lower-than-expected on a full-year basis
due to a
slow start to the season and broader macroeconomic
issues.
|
·
|
Continued
pressure from commodity costs that are likely to affect second-half
results.
|
·
|
The
impact of future lost sales and unplanned administrative expenses
- such
as legal and consulting fees - resulting from the product recalls.
This
impact excludes direct costs of the product recalls which are excluded
from adjusted earnings and does not currently include any potential
fines
or penalties in relation to the recalls or the potential for additional
recalls.
|
·
|
Adverse
weather conditions could adversely affect our sales and financial
results;
|
·
|
Our
historical seasonality could impair our ability to pay obligations
and
operating expenses as they come due and operating
expenses;
|
·
|
Our
substantial indebtedness could adversely affect our financial
health;
|
·
|
Public
perceptions regarding the safety of our products, particularly
in light of
our recently announced product recalls, could adversely affect
us;
|
·
|
Costs
associated with our recently announced product recalls and the
corresponding governmental investigation, including recall costs,
legal
and advertising expenses, lost sales and potential governmental
fines
could adversely affect our financial
results;
|
·
|
The
loss of one or more of our top customers could adversely affect
our
financial results because of the concentration of our sales to
a small
number of retail customers;
|
·
|
The
expiration of certain patents could substantially increase our
competition
in the United States;
|
·
|
Compliance
with environmental and other public health regulations could increase
our
cost of doing business; and
|
·
|
Our
significant international operations make us more susceptible to
fluctuations in currency exchange rates and to the costs of international
regulation.
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||||||||
March
29,
|
March
31,
|
%
|
March
29,
|
March
31,
|
%
|
|||||||||||||||||
Footnotes
|
2008
|
2007
|
Change
|
2008
|
2007
|
Change
|
||||||||||||||||
Net
sales
|
$
|
958.0
|
$
|
993.3
|
-4
|
%
|
$
|
1,266.7
|
$
|
1,264.5
|
0
|
%
|
||||||||||
Cost
of sales
|
612.6
|
624.9
|
850.0
|
840.8
|
||||||||||||||||||
Cost
of sales - product recalls
|
22.6
|
-
|
22.6
|
-
|
||||||||||||||||||
Gross
profit
|
322.8
|
368.4
|
-12
|
%
|
394.1
|
423.7
|
-7
|
%
|
||||||||||||||
%
of sales
|
33.7
|
%
|
37.1
|
%
|
31.1
|
%
|
33.5
|
%
|
||||||||||||||
Operating
expenses:
|
||||||||||||||||||||||
Selling,
general and administrative
|
208.4
|
203.0
|
3
|
%
|
352.7
|
345.2
|
2
|
%
|
||||||||||||||
SG&A
- product recalls
|
1.2
|
-
|
1.2
|
-
|
||||||||||||||||||
Other
income, net
|
(1.0
|
)
|
(1.1
|
)
|
(4.2
|
)
|
(3.4
|
)
|
||||||||||||||
Total
operating expenses
|
208.6
|
201.9
|
3
|
%
|
349.7
|
341.8
|
2
|
%
|
||||||||||||||
Income
from operations
|
114.2
|
166.5
|
-31
|
%
|
44.4
|
81.9
|
-46
|
%
|
||||||||||||||
%
of sales
|
11.9
|
%
|
16.8
|
%
|
3.5
|
%
|
6.5
|
%
|
||||||||||||||
Costs
related to refinancings
|
-
|
18.3
|
-
|
18.3
|
||||||||||||||||||
Interest
expense
|
23.5
|
17.9
|
42.5
|
26.1
|
||||||||||||||||||
Income
before taxes
|
90.7
|
130.3
|
-30
|
%
|
1.9
|
37.5
|
-95
|
%
|
||||||||||||||
Income
tax expense
|
32.7
|
46.9
|
0.7
|
13.5
|
||||||||||||||||||
Net
income
|
$
|
58.0
|
$
|
83.4
|
-30
|
%
|
$
|
1.2
|
$
|
24.0
|
-95
|
%
|
||||||||||
Basic
income per share
|
(1
|
)
|
$
|
0.90
|
$
|
1.26
|
-29
|
%
|
$
|
0.02
|
$
|
0.36
|
-94
|
%
|
||||||||
Diluted
income per share
|
(2
|
)
|
$
|
0.88
|
$
|
1.23
|
-28
|
%
|
$
|
0.02
|
$
|
0.35
|
-94
|
%
|
||||||||
Common
shares used in basic income per
share calculation
|
64.4
|
66.1
|
-3
|
%
|
64.3
|
66.6
|
-3
|
%
|
||||||||||||||
Common
shares and potential common shares used in diluted income per share
calculation
|
65.6 | 67.8 |
-3
|
%
|
65.7 | 68.4 |
-4
|
%
|
||||||||||||||
Results
of operations excluding restructuring, refinancing
charges, loss on impairment and other charges:
|
||||||||||||||||||||||
Adjusted
net income
|
(4
|
)
|
$
|
77.7
|
$
|
95.1
|
-18
|
%
|
$
|
20.9
|
$
|
35.7
|
-41
|
%
|
||||||||
Adjusted
diluted income per share
|
(2)
(4
|
)
|
$
|
1.19
|
$
|
1.40
|
-15
|
%
|
$
|
0.32
|
$
|
0.52
|
-39
|
%
|
||||||||
Adjusted
EBITDA
|
(3)
(4
|
)
|
$
|
145.7
|
$
|
184.2
|
-21
|
%
|
$
|
93.1
|
$
|
116.0
|
-20
|
%
|
||||||||
Pro
forma results as if the recapitalization transactions and
related debt restructuring occurred as of the the beginning
of each fiscal
year
|
||||||||||||||||||||||
Pro
forma adjusted net income
|
(4)
(5
|
)
|
$
|
77.7
|
$
|
89.2
|
-13
|
%
|
$
|
20.9
|
$
|
20.5
|
2
|
%
|
||||||||
Pro
forma adjusted diluted income per share
|
(4)
(5
|
)
|
$
|
1.19
|
$
|
1.37
|
-13
|
%
|
$
|
0.32
|
$
|
0.31
|
1
|
%
|
Three
Months Ended
|
||||||||||
March
29,
|
March
31,
|
|||||||||
2008
|
2007
|
%
Change
|
||||||||
Global
Consumer
|
$
|
801.9
|
$
|
852.3
|
-6
|
%
|
||||
Global
Professional
|
99.5
|
77.1
|
29
|
%
|
||||||
Scotts
LawnService®
|
32.0
|
33.7
|
-5
|
%
|
||||||
Corporate
& Other
|
24.6
|
30.2
|
-19
|
%
|
||||||
Consolidated
|
$
|
958.0
|
$
|
993.3
|
-4
|
%
|
Six
Months Ended
|
||||||||||
March
29,
|
March
31,
|
|||||||||
2008
|
2007
|
%
Change
|
||||||||
Global
Consumer
|
$
|
968.8
|
$
|
996.8
|
-3
|
%
|
||||
Global
Professional
|
161.9
|
133.6
|
21
|
%
|
||||||
Scotts
LawnService®
|
70.3
|
59.5
|
18
|
%
|
||||||
Corporate
& Other
|
65.7
|
74.6
|
-12
|
%
|
||||||
Consolidated
|
$
|
1,266.7
|
$
|
1,264.5
|
0
|
%
|
March
29,
|
March
31,
|
September
30,
|
||||||||
2008
|
2007
|
2007
|
||||||||
ASSETS
|
||||||||||
Current
assets
|
||||||||||
Cash
and cash equivalents
|
$
|
76.9
|
$
|
43.5
|
$
|
67.9
|
||||
Accounts
receivable, net
|
1,035.1
|
1,001.0
|
397.8
|
|||||||
Inventories,
net
|
625.1
|
571.9
|
405.9
|
|||||||
Prepaids
and other current assets
|
159.7
|
131.0
|
127.7
|
|||||||
Total
current assets
|
1,896.8
|
1,747.4
|
999.3
|
|||||||
Property,
plant and equipment, net
|
363.3
|
369.2
|
365.9
|
|||||||
Goodwill,
net
|
467.3
|
475.0
|
462.9
|
|||||||
Other
intangible assets, net
|
417.9
|
421.7
|
418.8
|
|||||||
Other
assets
|
25.6
|
29.5
|
30.3
|
|||||||
Total
assets
|
$
|
3,170.9
|
$
|
3,042.8
|
$
|
2,277.2
|
||||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
||||||||||
Current
liabilities
|
||||||||||
Current
portion of debt
|
$
|
281.8
|
$
|
23.7
|
$
|
86.4
|
||||
Accounts
payable
|
368.0
|
341.5
|
202.5
|
|||||||
Other
current liabilities
|
421.2
|
355.8
|
297.7
|
|||||||
Total
current liabilities
|
1,071.0
|
721.0
|
586.6
|
|||||||
Long-term
debt
|
1,445.9
|
1,783.2
|
1,031.4
|
|||||||
Other
liabilities
|
187.8
|
163.8
|
179.9
|
|||||||
Total
liabilities
|
2,704.7
|
2,668.0
|
1,797.9
|
|||||||
Shareholders'
equity
|
466.2
|
374.8
|
479.3
|
|||||||
Total
liabilities and shareholders' equity
|
$
|
3,170.9
|
$
|
3,042.8
|
$
|
2,277.2
|
Three
Months Ended March 29, 2008
|
Three
Months Ended March 31, 2007
|
||||||||||||||||||||||||
As
Reported
|
Product
Recalls
|
Adjusted
|
As
Reported
|
Costs
related to refinancings
|
Adjusted
|
Pro
Forma Adjustments
|
Pro
Forma
Adjusted
|
||||||||||||||||||
Net
sales
|
$
|
958.0
|
$
|
(19.0
|
)
|
$
|
977.0
|
$
|
993.3
|
$
|
-
|
$
|
993.3
|
$
|
-
|
$
|
993.3
|
||||||||
Cost
of sales
|
612.6
|
(12.0
|
)
|
624.6
|
624.9
|
-
|
624.9
|
-
|
624.9
|
||||||||||||||||
Cost
of sales - product recalls
|
22.6
|
22.6
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||
Gross
profit
|
322.8
|
(29.6
|
)
|
352.4
|
368.4
|
-
|
368.4
|
-
|
368.4
|
||||||||||||||||
%
of sales
|
33.7
|
%
|
36.1
|
%
|
37.1
|
%
|
37.1
|
%
|
37.1
|
%
|
|||||||||||||||
Operating
expenses:
|
|||||||||||||||||||||||||
Selling,
general and administrative
|
208.4
|
-
|
208.4
|
203.0
|
-
|
203.0
|
-
|
203.0
|
|||||||||||||||||
SG&A
- product recalls
|
1.2
|
1.2
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||
Other
income, net
|
(1.0
|
)
|
-
|
(1.0
|
)
|
(1.1
|
)
|
-
|
(1.1
|
)
|
-
|
(1.1
|
)
|
||||||||||||
Total
operating expenses
|
208.6
|
1.2
|
207.4
|
201.9
|
-
|
201.9
|
-
|
201.9
|
|||||||||||||||||
Income
from operations
|
114.2
|
(30.8
|
)
|
145.0
|
166.5
|
-
|
166.5
|
-
|
166.5
|
||||||||||||||||
%
of sales
|
11.9
|
%
|
14.8
|
%
|
16.8
|
%
|
16.8
|
%
|
16.8
|
%
|
|||||||||||||||
Costs
related to refinancings
|
-
|
-
|
-
|
18.3
|
18.3
|
-
|
-
|
-
|
|||||||||||||||||
Interest
expense
|
23.5
|
-
|
23.5
|
17.9
|
-
|
17.9
|
9.3
|
27.2
|
|||||||||||||||||
Income
before taxes
|
90.7
|
(30.8
|
)
|
121.5
|
130.3
|
(18.3
|
)
|
148.6
|
(9.3
|
)
|
139.3
|
||||||||||||||
Income
tax expense
|
32.7
|
(11.1
|
)
|
43.8
|
46.9
|
(6.6
|
)
|
53.5
|
(3.4
|
)
|
50.1
|
||||||||||||||
Net
income (reported, adjusted and pro forma)
|
$
|
58.0
|
$
|
(19.7
|
)
|
$
|
77.7
|
$
|
83.4
|
$
|
(11.7
|
)
|
$
|
95.1
|
$
|
(5.9
|
)
|
$
|
89.2
|
||||||
Basic
income per share
|
$
|
0.90
|
$
|
(0.31
|
)
|
$
|
1.21
|
$
|
1.26
|
$
|
(0.18
|
)
|
$
|
1.44
|
$
|
(0.04
|
)
|
$
|
1.41
|
||||||
Diluted
income per share
|
$
|
0.88
|
$
|
(0.30
|
)
|
$
|
1.19
|
$
|
1.23
|
$
|
(0.17
|
)
|
$
|
1.40
|
$
|
(0.03
|
)
|
$
|
1.37
|
||||||
Common
shares used in basic income per
share calculation
|
64.4
|
64.4
|
64.4
|
66.1
|
66.1
|
66.1
|
63.4
|
||||||||||||||||||
Common
shares and potential common shares
used
in diluted income per share calculation
|
65.6
|
65.6
|
65.6
|
67.8
|
67.8
|
67.8
|
65.2
|
||||||||||||||||||
|
|||||||||||||||||||||||||
Net
income
|
58.0
|
83.4
|
|||||||||||||||||||||||
Income
tax expense
|
32.7
|
46.9
|
|||||||||||||||||||||||
Interest
expense
|
23.5
|
17.9
|
|||||||||||||||||||||||
Restructuring
and other charges
|
14.1
|
-
|
|||||||||||||||||||||||
Costs
related to refinancing
|
-
|
18.3
|
|||||||||||||||||||||||
Depreciation
|
13.3
|
13.7
|
|||||||||||||||||||||||
Amortization,
including marketing fees
|
4.1
|
4.0
|
|||||||||||||||||||||||
Adjusted
EBITDA
|
$
|
145.7
|
$
|
184.2
|
Six
Months Ended March 29, 2008
|
Six
Months Ended March 31, 2007
|
||||||||||||||||||||||||
As
Reported
|
Product
Recalls
|
Adjusted
|
As
Reported
|
Costs
related to refinancings
|
Adjusted
|
Pro
Forma Adjustments
|
Pro
Forma
Adjusted
|
||||||||||||||||||
Net
sales
|
$
|
1,266.7
|
$
|
(19.0
|
)
|
$
|
1,285.7
|
$
|
1,264.5
|
$
|
-
|
$
|
1,264.5
|
$
|
-
|
$
|
1,264.5
|
||||||||
Cost
of sales
|
850.0
|
(12.0
|
)
|
862.0
|
840.8
|
-
|
840.8
|
-
|
840.8
|
||||||||||||||||
Cost
of sales - product recalls
|
22.6
|
22.6
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||
Gross
profit
|
394.1
|
(29.6
|
)
|
423.7
|
423.7
|
-
|
423.7
|
-
|
423.7
|
||||||||||||||||
%
of sales
|
31.1
|
%
|
33.0
|
%
|
33.5
|
%
|
33.5
|
%
|
33.5
|
%
|
|||||||||||||||
Operating
expenses:
|
|||||||||||||||||||||||||
Selling,
general and administrative
|
352.7
|
-
|
352.7
|
345.2
|
-
|
345.2
|
-
|
345.2
|
|||||||||||||||||
SG&A
- product recalls
|
1.2
|
1.2
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||
Other
income, net
|
(4.2
|
)
|
-
|
(4.2
|
)
|
(3.4
|
)
|
-
|
(3.4
|
)
|
-
|
(3.4
|
)
|
||||||||||||
Total
operating expenses
|
349.7
|
1.2
|
348.5
|
341.8
|
-
|
341.8
|
-
|
341.8
|
|||||||||||||||||
Income
from operations
|
44.4
|
(30.8
|
)
|
75.2
|
81.9
|
-
|
81.9
|
-
|
81.9
|
||||||||||||||||
%
of sales
|
3.5
|
%
|
5.8
|
%
|
6.5
|
%
|
6.5
|
%
|
6.5
|
%
|
|||||||||||||||
Costs
related to refinancings
|
-
|
-
|
-
|
18.3
|
18.3
|
-
|
-
|
-
|
|||||||||||||||||
Interest
expense
|
42.5
|
-
|
42.5
|
26.1
|
-
|
26.1
|
23.6
|
49.7
|
|||||||||||||||||
Income
before taxes
|
1.9
|
(30.8
|
)
|
32.7
|
37.5
|
(18.3
|
)
|
55.8
|
(23.6
|
)
|
32.2
|
||||||||||||||
Income
tax expense
|
0.7
|
(11.1
|
)
|
11.8
|
13.5
|
(6.6
|
)
|
20.1
|
(8.4
|
)
|
11.7
|
||||||||||||||
Net
income (reported, adjusted and pro forma)
|
$
|
1.2
|
$
|
(19.7
|
)
|
$
|
20.9
|
$
|
24.0
|
$
|
(11.7
|
)
|
$
|
35.7
|
$
|
(15.2
|
)
|
$
|
20.5
|
||||||
Basic
income per share
|
$
|
0.02
|
$
|
(0.31
|
)
|
$
|
0.33
|
$
|
0.36
|
$
|
(0.18
|
)
|
$
|
0.54
|
$
|
(0.04
|
)
|
$
|
0.32
|
||||||
Diluted
income per share
|
$
|
0.02
|
$
|
(0.30
|
)
|
$
|
0.32
|
$
|
0.35
|
$
|
(0.17
|
)
|
$
|
0.52
|
$
|
(0.03
|
)
|
$
|
0.31
|
||||||
Common
shares used in basic income per
share calculation
|
64.3
|
64.3
|
64.3
|
66.6
|
66.6
|
66.6
|
63.0
|
||||||||||||||||||
Common
shares and potential common shares
used in diluted income per share calculation
|
65.7
|
65.7
|
65.7
|
68.4
|
68.4
|
68.4
|
65.0
|
||||||||||||||||||
Net
income
|
1.2
|
24.0
|
|||||||||||||||||||||||
Income
tax expense
|
0.7
|
13.5
|
|||||||||||||||||||||||
Interest
expense
|
42.5
|
26.1
|
|||||||||||||||||||||||
Restructuring
and other charges
|
14.1
|
-
|
|||||||||||||||||||||||
Costs
related to refinancing
|
-
|
18.3
|
|||||||||||||||||||||||
Depreciation
|
26.4
|
26.4
|
|||||||||||||||||||||||
Amortization,
including marketing fees
|
8.2
|
7.7
|
|||||||||||||||||||||||
Adjusted
EBITDA
|
$
|
93.1
|
$
|
116.0
|
(1)
|
Basic
earnings per common share is calculated by dividing net income
by average
common shares outstanding during the period.
|
|||||
(2)
|
Diluted
income per share is calculated by dividing net income by the average
common shares and dilutive potential common shares (common stock
options,
stock appreciation rights, and restricted stock) outstanding during
the
period.
|
|||||
(3)
|
"Adjusted
EBITDA" is defined as net income before interest, taxes, depreciation
and
amortization as well as certain other items such as the impact
of
discontinued operations, the cumulative effect of changes in accounting,
costs associated with debt refinancing and other non-recurring,
non-cash
items effecting net income. Adjusted EBITDA is not intended to
represent
cash flow from operations as defined by generally accepted accounting
principles and should not be used as an alternative to net income
as an
indicator of operating performance or to cash flow as a measure
of
liquidity.
|
|||||
(4)
|
The
Reconciliation of non-GAAP Disclosure Items includes the following
non-GAAP financial measures:
Adjusted
net income and adjusted diluted income per share - These measures
exclude
charges or credits relating to refinancings, impairments, restructurings,
product recalls, and other unusual items as such costs or gains
relate to
discrete projects or transactions that are apart from and not indicative
of the results of the operations of the business.
Pro
forma adjusted net income and pro forma adjusted diluted income
per share
- These measures include interest expense and diluted shares which
have
been computed as if the recapitalization transactions were completed
as
described in Note 5 below.
Adjusted
EBITDA - The presentation of adjusted EBITDA is provided as a convenience
to the Company's lenders because adjusted EBITDA is a component
of certain
debt covenants.
Free
cash flow - This annual measure is often used by analysts and
creditors as
a measure of a company’s ability to service debt, reinvest in the business
beyond normal capital expenditures, and return cash to shareholders.
Free
cash flow is equivalent to cash provided by operating activities
as
defined by generally accepted accounting principles less capital
expenditures.
The
Company believes that the disclosure of these non-GAAP financial
measures
provides useful information to investors or other
users of the financial statements, such as
lenders.
|
|||||
(5)
|
During
the second quarter of fiscal 2007, Scotts Miracle-Gro completed
a
significant recapitalization plan. The objective of this plan,
announced
on December 12, 2006, was to return $750 million to the Company's
shareholders. This was accomplished via a share repurchase that
totaled
$245.5 million, or 4.5 million shares, which was completed via
a modified
Dutch auction tender offer on February 14, 2007, and a special
one-time
cash dividend of $8.00 per share, totaling $508.0 million, which
was paid
on March 5, 2007 to shareholders of record as of February 26, 2007.
|
|||||
In
order to fund these transactions, the Company entered into new
credit
facilities aggregating to $2.15 billion. As part of this debt
restructuring, the Company launched a successful tender offer for
all of
its $200 million 6 5/8% senior subordinated notes, which were retired
in
the second quarter.
|
||||||
Subsequent
to the completion of this recapitalization, the Company's interest
expense
has been and will be significantly higher as a result of the borrowings
incurred to fund the cash returned to shareholders and related
expenses.
The following pro forma incremental interest expense has been determined
as if the Company had completed these recapitalization transactions
as of
October 1, 2006 for fiscal 2007. Borrowing rates in effect as of
March 30,
2007 were used to compute this pro forma interest expense. As the
recapitalization involved a share repurchase, pro forma diluted
shares are
also provided.
|
Fiscal
2007
|
|||||||
Q1
|
Q2
|
||||||
Incremental
interest on recapitalization borrowings
|
$
|
13.1
|
$
|
8.7
|
|||
New
credit facility interest rate differential
|
1.0
|
0.5
|
|||||
Incremental
amortization of new credit facility fees
|
0.2
|
0.1
|
|||||
Pro
forma incremental interest from recapitalization
|
$
|
14.3
|
$
|
9.3
|
|||
Year-to-date
incremental interest
|
$
|
23.6
|
|||||
Common
shares and potential common shares used
|
|||||||
in
diluted income per share calculation
|
67.2
|
67.8
|
|||||
Incremental
impact of repurchased shares
|
(4.5
|
)
|
(2.7
|
)
|
|||
Incremental
impact on potential common shares
|
-
|
0.1
|
|||||
Pro
forma diluted shares
|
62.7
|
65.2
|
|||||
Year-to-date
pro forma diluted shares
|
65.0
|